128 related articles for article (PubMed ID: 27017401)
1. High-grade transformation of acinic cell carcinoma: an inadequately treated entity?
Chintakuntlawar AV; Shon W; Erickson-Johnson M; Bilodeau E; Jenkins SM; Davidson JA; Keeney MG; Rivera M; Price DL; Moore EJ; Olsen KD; Kasperbauer JL; Foote RL; Price KA; García JJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 May; 121(5):542-549.e1. PubMed ID: 27017401
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
3. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
[TBL] [Abstract][Full Text] [Related]
4. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma.
Chiosea SI; Griffith C; Assaad A; Seethala RR
Am J Surg Pathol; 2012 Mar; 36(3):343-50. PubMed ID: 22301503
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of acinic cell carcinoma and secretory carcinoma of the parotid gland.
Terada T; Kawata R; Noro K; Higashino M; Nishikawa S; Haginomori SI; Kurisu Y; Kuwabara H; Hirose Y
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3461-3466. PubMed ID: 31440815
[TBL] [Abstract][Full Text] [Related]
6. Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
Barasch N; Gong X; Kwei KA; Varma S; Biscocho J; Qu K; Xiao N; Lipsick JS; Pelham RJ; West RB; Pollack JR
PLoS One; 2017; 12(2):e0171265. PubMed ID: 28212443
[TBL] [Abstract][Full Text] [Related]
7. Ten patients with high-grade transformation of acinic cell carcinomas: Expression profiling of β-catenin and cyclin D1 is useful.
Yue LE; Samankan S; Liu X; Sharif KF; Everest S; Singh T; Dhorajiya P; Baik FM; Khorsandi A; Stevens TM; Brandwein-Weber M; Urken ML
Pathol Res Pract; 2020 Feb; 216(2):152767. PubMed ID: 31812438
[TBL] [Abstract][Full Text] [Related]
8. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
9. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
[TBL] [Abstract][Full Text] [Related]
10. High grade transformation of salivary gland acinic cell carcinoma with emphasis on histological diagnosis and clinical implications.
Bury D; Dafalla M; Ahmed S; Hellquist H
Pathol Res Pract; 2016 Nov; 212(11):1059-1063. PubMed ID: 27623207
[TBL] [Abstract][Full Text] [Related]
11. Acinic cell carcinoma of the salivary gland in the adult and paediatric population: a survival analysis.
Sideris A; Rao A; Maher N; Parker A; Crawford J; Smee R; Jacobson I; Gallagher R
ANZ J Surg; 2021 Jun; 91(6):1233-1239. PubMed ID: 33205582
[TBL] [Abstract][Full Text] [Related]
12. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
[TBL] [Abstract][Full Text] [Related]
14. Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.
Hsieh MS; Chou YH; Yeh SJ; Chang YL
Virchows Arch; 2015 Aug; 467(2):145-53. PubMed ID: 25976476
[TBL] [Abstract][Full Text] [Related]
15. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.
Rooper LM; Karantanos T; Ning Y; Bishop JA; Gordon SW; Kang H
Am J Surg Pathol; 2018 Aug; 42(8):1121-1126. PubMed ID: 29683815
[TBL] [Abstract][Full Text] [Related]
16. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study.
Triantafillidou K; Iordanidis F; Psomaderis K; Kalimeras E
J Oral Maxillofac Surg; 2010 Oct; 68(10):2489-96. PubMed ID: 20678839
[TBL] [Abstract][Full Text] [Related]
17. Fine needle aspiration of salivary gland carcinomas with high-grade transformation: A multi-institutional study of 22 cases and review of the literature.
Nakaguro M; Faquin WC; Baloch ZW; Cantley RL; Compton ML; Ely KA; Holmes BJ; Hu R; Kerr DA; Montone KT; Nishino M; Pantanowitz L; Rossi ED; Sadow PM
Cancer Cytopathol; 2021 Apr; 129(4):318-325. PubMed ID: 33211402
[TBL] [Abstract][Full Text] [Related]
18. The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases.
Griffith CC; Stelow EB; Saqi A; Khalbuss WE; Schneider F; Chiosea SI; Seethala RR
Cancer Cytopathol; 2013 May; 121(5):234-41. PubMed ID: 23225548
[TBL] [Abstract][Full Text] [Related]
19. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
Drilon A; Li G; Dogan S; Gounder M; Shen R; Arcila M; Wang L; Hyman DM; Hechtman J; Wei G; Cam NR; Christiansen J; Luo D; Maneval EC; Bauer T; Patel M; Liu SV; Ou SH; Farago A; Shaw A; Shoemaker RF; Lim J; Hornby Z; Multani P; Ladanyi M; Berger M; Katabi N; Ghossein R; Ho AL
Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.
Skaugen JM; Seethala RR; Chiosea SI; Landau MS
Cancer Cytopathol; 2021 Feb; 129(2):104-113. PubMed ID: 32809265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
